Potential conflict of interest: Nothing to report.
Steatohepatitis/Metabolic Liver Disease
Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice
Version of Record online: 27 MAR 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 5, pages 1791–1802, May 2014
How to Cite
Han, S.-i., Komatsu, Y., Murayama, A., Steffensen, K. R., Nakagawa, Y., Nakajima, Y., Suzuki, M., Oie, S., Parini, P., Vedin, L.-L., Kishimoto, H., Shimano, H., Gustafsson, J.-Å. and Yanagisawa, J. (2014), Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice. Hepatology, 59: 1791–1802. doi: 10.1002/hep.26951
This work was supported by the Research Fellowship (to S.H. and Y.K.) from the Japan Society for the Promotion of Science. J-A.G. was supported by the Swedish Cancer Society, the Texas Emerging Technology Fund (under Agreement 18, no. 300-9-1958), and the Robert A. Welch Foundation (E-0004).
- Issue online: 23 APR 2014
- Version of Record online: 27 MAR 2014
- Accepted manuscript online: 26 NOV 2013 03:25AM EST
- Manuscript Accepted: 19 NOV 2013
- Manuscript Received: 10 JAN 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.